470 related articles for article (PubMed ID: 11134279)
1. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
[TBL] [Abstract][Full Text] [Related]
2. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus).
Strestik BD; Olbrich ARM; Hasenkrug KJ; Dittmer U
J Gen Virol; 2001 Jun; 82(Pt 6):1349-1354. PubMed ID: 11369878
[TBL] [Abstract][Full Text] [Related]
3. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
4. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
5. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
[TBL] [Abstract][Full Text] [Related]
7. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
8. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
9. Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.
Stromnes IM; Dittmer U; Schumacher TN; Schepers K; Messer RJ; Evans LH; Peterson KE; Race B; Hasenkrug KJ
J Virol; 2002 Mar; 76(5):2225-32. PubMed ID: 11836400
[TBL] [Abstract][Full Text] [Related]
10. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.
Iwashiro M; Peterson K; Messer RJ; Stromnes IM; Hasenkrug KJ
J Virol; 2001 Jan; 75(1):52-60. PubMed ID: 11119573
[TBL] [Abstract][Full Text] [Related]
12. Effects of type I interferons on Friend retrovirus infection.
Gerlach N; Schimmer S; Weiss S; Kalinke U; Dittmer U
J Virol; 2006 Apr; 80(7):3438-44. PubMed ID: 16537611
[TBL] [Abstract][Full Text] [Related]
13. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
14. Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.
Kato M; Tsuji-Kawahara S; Kawasaki Y; Kinoshita S; Chikaishi T; Takamura S; Fujisawa M; Kawada A; Miyazawa M
J Virol; 2015 Jan; 89(2):1468-73. PubMed ID: 25378499
[TBL] [Abstract][Full Text] [Related]
15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
16. High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas.
Beaty RM; Rulli K; Bost KL; Pantginis J; Lenz J; Levy LS
Virology; 1999 Sep; 261(2):253-62. PubMed ID: 10497110
[TBL] [Abstract][Full Text] [Related]
17. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking IL-12 develop polarized Th1 cells during viral infection.
Schijns VE; Haagmans BL; Wierda CM; Kruithof B; Heijnen IA; Alber G; Horzinek MC
J Immunol; 1998 Apr; 160(8):3958-64. PubMed ID: 9558103
[TBL] [Abstract][Full Text] [Related]
19. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
